Compare Stocks → The system that called 2023’s top 7 stocks is at it again… (From WealthPress) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:EUCROTCMKTS:HCCCNASDAQ:OTECNASDAQ:OTRANASDAQ:VSAC Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEUCREucrates Biomedical Acquisition$10.04$10.08$9.87▼$10.25$42.27M-0.072,287 shs12,700 shsHCCCHealthcare Capital$12.74$8.20▼$14.78$437.87MN/A410,825 shs376,700 shsOTECOceanTech Acquisitions I$11.75$11.75$10.50▼$12.95$41.09M0.037,160 shsN/AOTRAOTR Acquisition$9.91$10.15$8.08▼$15.30$125.61M-0.07194,353 shs838,214 shsVSACVision Sensing Acquisition$11.45$11.22$10.50▼$11.85$49.81M0.0212,453 shs16,457 shsBeginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEUCREucrates Biomedical Acquisition0.00%0.00%0.00%0.00%0.00%HCCCHealthcare Capital0.00%0.00%0.00%0.00%0.00%OTECOceanTech Acquisitions I0.00%0.00%0.00%0.00%+9.10%OTRAOTR Acquisition0.00%0.00%0.00%0.00%0.00%VSACVision Sensing Acquisition0.00%+0.32%+2.23%+2.88%+8.94%Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new reportMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEUCREucrates Biomedical AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AHCCCHealthcare CapitalN/AN/AN/AN/AN/AN/AN/AN/AOTECOceanTech Acquisitions IN/AN/AN/AN/AN/AN/AN/AN/AOTRAOTR AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AVSACVision Sensing AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEUCREucrates Biomedical AcquisitionN/AN/AN/AN/AHCCCHealthcare CapitalN/AN/AN/AN/AOTECOceanTech Acquisitions IN/AN/AN/AN/AOTRAOTR AcquisitionN/AN/AN/AN/AVSACVision Sensing AcquisitionN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEUCREucrates Biomedical AcquisitionN/AN/A$0.81 per share12.36($1.25) per shareN/AHCCCHealthcare CapitalN/AN/AN/AN/A$0.06 per shareN/AOTECOceanTech Acquisitions IN/AN/A$0.73 per share16.05($3.16) per shareN/AOTRAOTR AcquisitionN/AN/A$0.37 per share26.80($0.55) per shareN/AVSACVision Sensing AcquisitionN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEUCREucrates Biomedical Acquisition$2.42MN/A0.00∞N/AN/A-62.82%2.95%N/AHCCCHealthcare CapitalN/AN/A0.00N/AN/AN/AN/AN/AN/AOTECOceanTech Acquisitions I$1.97MN/A0.00∞N/AN/AN/A-8.58%N/AOTRAOTR Acquisition$4.69MN/A0.00∞N/AN/A-46.92%2.11%N/AVSACVision Sensing AcquisitionN/AN/A0.00∞N/AN/AN/AN/A5/15/2024 (Estimated)DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEUCREucrates Biomedical AcquisitionN/AN/AN/AN/AN/AHCCCHealthcare CapitalN/AN/AN/AN/AN/AOTECOceanTech Acquisitions IN/AN/AN/AN/AN/AOTRAOTR AcquisitionN/AN/AN/AN/AN/AVSACVision Sensing AcquisitionN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEUCREucrates Biomedical AcquisitionN/A2.032.03HCCCHealthcare CapitalN/A1.901.90OTECOceanTech Acquisitions IN/A0.030.03OTRAOTR AcquisitionN/A0.061.91VSACVision Sensing AcquisitionN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipEUCREucrates Biomedical Acquisition56.02%HCCCHealthcare Capital70.49%OTECOceanTech Acquisitions I15.26%OTRAOTR Acquisition89.65%VSACVision Sensing Acquisition27.91%Insider OwnershipCompanyInsider OwnershipEUCREucrates Biomedical Acquisition19.50%HCCCHealthcare CapitalN/AOTECOceanTech Acquisitions I68.00%OTRAOTR AcquisitionN/AVSACVision Sensing Acquisition6.18%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableEUCREucrates Biomedical Acquisition44.21 million3.39 millionNot OptionableHCCCHealthcare Capital234.37 millionN/ANot OptionableOTECOceanTech Acquisitions I43.50 million1.12 millionNot OptionableOTRAOTR AcquisitionN/A12.68 millionN/ANot OptionableVSACVision Sensing Acquisition2,0214.35 million4.08 millionNot OptionableVSAC, OTEC, OTRA, HCCC, and EUCR HeadlinesSourceHeadlineVision Sensing Acquisition Corp. Receives Positive Ruling from Nasdaq Hearings Panelglobenewswire.com - April 19 at 3:00 PMVision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to May 3, 2024globenewswire.com - April 2 at 11:00 AMVision Sensing Acquisition Corp. Announces Intention to Extend Period to Consummate Initial Business Combination to May 3, 2024globenewswire.com - March 29 at 6:45 AMVision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to April 3, 2024globenewswire.com - March 4 at 2:25 PMVision Sensing Acquisition Corp. Announces Intention to Extend Period to Consummate Initial Business Combination to April 3, 2024globenewswire.com - February 28 at 1:00 PMVision Sensing Acquisition Corp. Announces Filing of Form 10-Q with the SEC For the Quarterly Period Ended September 30, 2023, Regaining Compliance with the Filing Requirement in Nasdaq Listing Rule 5250(c)(1)globenewswire.com - February 9 at 3:22 PMMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains ImminentHow to Protect your Portfolio Against a Rising VIXApril 10, 2024 9:22 AMView How to Protect your Portfolio Against a Rising VIXCan Altimmune get its GLP-1 Drug to Market Before Cash Rush Out? April 9, 2024 6:07 AMView Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out? Biotech Sector Nears Breakout: Will it Outperform in Q2?April 3, 2024 6:10 AMView Biotech Sector Nears Breakout: Will it Outperform in Q2?All Headlines Company DescriptionsEucrates Biomedical AcquisitionNASDAQ:EUCREucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.Healthcare CapitalOTCMKTS:HCCCHealthcare Capital Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Wilmington, Delaware.OceanTech Acquisitions INASDAQ:OTECOceanTech Acquisitions I Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization/similar business combination with one/more businesses in the leisure marine, yachting, and superyachting industries. OceanTech Acquisitions I Corp. was incorporated in 2021 and is based in New York, New York. OceanTech Acquisitions I Corp. operates as a subsidiary of Aspire Acquisition LLC.OTR AcquisitionNASDAQ:OTRAOTR Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Miami, Florida.Vision Sensing AcquisitionNASDAQ:VSACVision Sensing Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on companies with operations in vision sensing technologies, including hardware chip solutions, VST-related application software, artificial intelligence, and other peripheral technologies that assist to integrate and/or supplement VST applications. The company was incorporated in 2021 and is based in Miami, Florida. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
